BioCentury | Aug 26, 2020
Deals
Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues
...has completed Phase Ia testing to treat solid tumors. Forbius itself was spun out of YM Biosciences Inc....